Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03507036 · ClinicalTrials.gov registry record · NA

Radio Frequency Microneedling for Suprapatellar Skin

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03507036 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03507036, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The human skin aging process is characterized by thinning dermis, atrophy of the extracellular matrix, and reduced collagen synthesis. Loss of collagen in the dermis is of aesthetic concern, as it is the main structural support in the dermis and its loss results in skin laxity. Photo-damaged skin, mostly due to UVR, causes degradation of elastic fibers. This is histologically seen as disorganized tangles of elastin. Additionally, as humans age, skin tends to appear more dry due to its poor hydration and turgor capacity. The use of minimally invasive aesthetic treatments in reducing signs of aging has been gaining in popularity over surgical treatments in recent years. Several energy types including, laser, radiofrequency, infrared, and ultrasound, have been developed for facial rejuvenation. These treatments induce controlled thermal damage into the dermis and cause collagen contraction and neocollagenesis resulting in skin tightening over several months. For improving appearance of other anatomical areas, micro-focused ultrasound has been the preferred method, but has shown limited success in tightening the suprapatellar skin. As with facial skin aging, the suprapatellar skin loses elasticity with age and begins to sag. Noninvasive treatments used for the face may also be used in other anatomical areas to produce the same effects of tightening. Minimally invasive bipolar radiofrequency produces a controlled thermal injury in a fractional manner without damaging the dermal-epidermal junction, epidermis or subcutis. Radiofrequency, unlike lasers, are chromophore-independent providing better penetration than lasers, and spare sweat glands, sebaceous glands, and hair follicles.

Interventions

  • DEVICE Profound system

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-03-15
Est. Completion 2019-05-01
Phase NA

What the Registry Record Tells You About NCT03507036

The ClinicalTrials.gov registry entry for NCT03507036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Profound system is the first listed.

NCT03507036 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03507036 about?

NCT03507036 is a clinical study titled "Radio Frequency Microneedling for Suprapatellar Skin". The human skin aging process is characterized by thinning dermis, atrophy of the extracellular matrix, and reduced collagen synthesis. Loss of collagen in the dermis is of aesthetic concern, as it is the main structural support in the dermis and its loss results in skin laxity. Photo-damaged skin, m...

What is the current status of trial NCT03507036?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-03-15. Estimated completion is 2019-05-01.

What interventions are being tested in trial NCT03507036?

The interventions under investigation include: Profound system (DEVICE).

Who is sponsoring clinical trial NCT03507036?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.